Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
$12.94
-0.5%
$13.06
$11.17
$13.97
N/AN/A105,197 shs99,686 shs
BTC
ClearShares Piton Intermediate Fixed Income ETF
$91.75
+0.3%
$91.14
$98.48
$100.89
$29.82MN/A1,456 shs560 shs
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
$80.39
-0.8%
$80.20
$65.54
$82.62
$156.77M1.225,609 shs30,722 shs
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$3.16
-8.4%
$3.52
$2.27
$44.80
$3.41M1.9212,370 shs171,203 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
-0.46%-0.92%+0.15%-0.46%+14.61%
BTC
ClearShares Piton Intermediate Fixed Income ETF
0.00%+0.02%+0.22%-0.75%-7.72%
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
-0.79%+0.40%+1.09%+2.33%+18.05%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
-8.28%-31.61%-5.01%-39.09%+315,499,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
N/AN/AN/AN/AN/AN/AN/AN/A
BTC
ClearShares Piton Intermediate Fixed Income ETF
N/AN/AN/AN/AN/AN/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/AN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
N/AN/AN/AN/A
BTC
ClearShares Piton Intermediate Fixed Income ETF
0.00
N/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
0.00
N/A$88.4710.04% Upside
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
$39.39MN/AN/AN/AN/AN/A
BTC
ClearShares Piton Intermediate Fixed Income ETF
N/AN/AN/AN/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$14.73M0.23N/AN/A$4.25 per share0.74

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
N/AN/A0.00N/AN/AN/AN/AN/A
BTC
ClearShares Piton Intermediate Fixed Income ETF
N/AN/A0.00N/AN/AN/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/A11.93N/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
-$9.64M-$109.09N/AN/A-80.76%-304.39%-81.20%N/A

Latest NBY, BGT, FAB, BTC, and IXI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024Q1 2024
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A-$4.90-$4.90-$0.13N/A$2.63 million
3/26/2024Q4 2023
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A-$33.25-$33.25-$0.57N/A$3.73 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
$1.4010.82%+22.54%N/A3 Years
BTC
ClearShares Piton Intermediate Fixed Income ETF
$0.020.02%N/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
$1.481.84%N/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/A

Latest NBY, BGT, FAB, BTC, and IXI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2024
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
Monthly$0.1211.14%5/14/20245/15/20245/31/2024
4/1/2024
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
Monthly$0.1210.98%4/12/20244/15/20244/30/2024
3/20/2024
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
Quarterly$0.24303/21/20243/22/20243/28/2024
(Data available from 1/1/2013 forward)

Debt

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
N/AN/AN/ANot Optionable
BTC
ClearShares Piton Intermediate Fixed Income ETF
147,000325,000N/ANot Optionable
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
147,0001.95 millionN/ANot Optionable
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
241.08 million1.08 millionNot Optionable

NBY, BGT, FAB, BTC, and IXI Headlines

Recent News About These Companies

StockNews.com Begins Coverage on NovaBay Pharmaceuticals (NYSE:NBY)
NovaBay Pharmaceuticals: Q4 Earnings Insights
NioBay Metals closes option agreement to acquire Foothills property

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BlackRock Floating Rate Income Trust logo

BlackRock Floating Rate Income Trust

NYSE:BGT
BlackRock Floating Rate Income Trust is a close ended fixed income mutual fund launched by BlackRoack Inc. The fund is co-managed by BlackRock Advisors, LLC and BlackRock Financial Management, Inc. It invests in the fixed income markets across the globe while focusing on the United States. The fund invests in bonds of companies operating across diversified sectors. It invests in corporate bonds with average effective duration of its portfolio will be no more than 1.5 years. The fund was formerly known as BlackRock Global Floating Rate Income Trust. BlackRock Floating Rate Income Trust was formed on August 30, 2004 and is domiciled in the United States.

ClearShares Piton Intermediate Fixed Income ETF

NYSEARCA:BTC
First Trust Multi Cap Value AlphaDEX Fund logo

First Trust Multi Cap Value AlphaDEX Fund

NASDAQ:FAB
The First Trust Multi Cap Value AlphaDEX Fund (FAB) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Multi Cap Value index. The fund tracks an index that uses fundamental factors to select and weight value stocks from the Nasdaq US Select Indices. FAB was launched on May 8, 2007 and is managed by First Trust.
NovaBay Pharmaceuticals logo

NovaBay Pharmaceuticals

NYSE:NBY
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.